Will Sovaldi, Drive Gilead Sciences, Inc. (GILD) To The Top Of The Biopharm Industry?
3/25/2014 8:13:18 AM
Gilead has been making a lot of headlines lately with its new drug for hepatitis C, Sovaldi. This is an interferon-free oral drug that eliminates this virus in a large number of patients. This alone would be notable, but Gilead is going one step better. It is developing a combination of Sovaldi with another of its drugs, GS-5816 and this promises to cure all types of hepatitis C with a single pill. This has been the dream of anti-viral researchers for decades.
Help employers find you! Check out all the jobs and post your resume.
comments powered by